NYSEARCA:REVS Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News $26.57 -0.01 (-0.04%) As of 07/18/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock About Columbia Research Enhanced Value ETF (NYSEARCA:REVS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get REVS alerts:Sign Up Key Stats Today's Range$26.50▼$26.6650-Day Range$24.99▼$26.8152-Week Range$21.79▼$27.03Volume8,900 shsAverage Volume11,290 shsMarket Capitalization$78.38 millionAssets Under Management$78.26 millionDividend Yield1.73%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF Overview The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia. Read More Columbia Research Enhanced Value ETF ExpensesTypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.19%0.58%0.56%0.51%0.53%Other Expenses0.00%0.27%0.56%0.59%0.56%Total Expense0.19%0.65%0.76%0.74%0.73%Fee Waiver0.00%-0.23%-0.66%-0.71%-0.63%Net Expense0.19%0.62%0.63%0.58%0.60% Receive REVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address REVS ETF News HeadlinesColumbia Research Enhanced Core ETF (ARCA:RECS), Top HoldingsJuly 8, 2025 | benzinga.comInvesting With Training Wheels: How Buffer ETFs Can Help Mitigate RiskMarch 2, 2025 | theglobeandmail.comA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.July 19 at 2:00 AM | American Alternative (Ad)Columbia Research Enhanced Real Estate ETFDecember 23, 2024 | investing.comREVS Columbia Research Enhanced Value ETFOctober 17, 2024 | seekingalpha.comFEPY ETF: Combining Income and Growth Opportunities for Canadian InvestorsOctober 2, 2024 | theglobeandmail.comSee More Headlines REVS ETF - Frequently Asked Questions How have REVS shares performed this year? Columbia Research Enhanced Value ETF's stock was trading at $24.73 at the beginning of the year. Since then, REVS stock has increased by 7.4% and is now trading at $26.57. Who are Columbia Research Enhanced Value ETF's major shareholders? Top institutional investors of Columbia Research Enhanced Value ETF include Wealth Enhancement Advisory Services LLC (3.07%). How do I buy shares of Columbia Research Enhanced Value ETF? Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Columbia Research Enhanced Value ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Columbia Research Enhanced Value ETF investors own include Geo Group (GEO), Global X SuperDividend REIT ETF (SRET), BlackRock Capital Investment (BKCC), British American Tobacco (BTI), Energy Transfer (ET), International Business Machines (IBM) and Annaly Capital Management (NLY). Fund Details IssuerColumbia Fund NameColumbia Research Enhanced Value ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:REVS Inception Date9/25/2019 Fund ManagerChristopher Lo, Jason Wang WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkThe Beta Advantage Research Enhanced U.S. Value Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings315 Fund Statistics Assets Under Management$78.26 million Average Daily Volume$0.00 Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorColumbia Management Investment Advisers, LLC CustodianThe Bank of New York Mellon Corporation DistributorALPS Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest5,800 shs Miscellaneous Outstanding Shares2,950,000Beta0.89 Creation Unit50,000 Creation Fee$500.00 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report Top 10 REVS HoldingsJPMorgan Chase & Co. (NYSE:JPM)Holding Weight: 5.31%Cisco Systems (NASDAQ:CSCO)Holding Weight: 3.93%Philip Morris International (NYSE:PM)Holding Weight: 3.67%Exxon Mobil (NYSE:XOM)Holding Weight: 2.83%Bank of America (NYSE:BAC)Holding Weight: 2.52%Medtronic (NYSE:MDT)Holding Weight: 2.39%RTX (NYSE:RTX)Holding Weight: 2.22%Wells Fargo & Company (NYSE:WFC)Holding Weight: 2.15%Bristol Myers Squibb (NYSE:BMY)Holding Weight: 2.07%Caterpillar (NYSE:CAT)Holding Weight: 1.75%Full Holdings DetailsREVS Sector ExposureREVS Industry Exposure This page (NYSEARCA:REVS) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free REVS Stock Alerts